If you’re interested in taking a glucagon-like peptide-1(GLP-1) receptor agonist for weight loss, you need a valid ...

A new triple-hormone weight-loss drug shows impressive results in clinical trials, but doctors are already prescribing it and ...

Liraglutide, under the brand name, Saxenda, is FDA-approved for weight management or weight loss in some cases. Saxenda is ...

But with GLP-1 drugs, she said, “everyone is kind of iterating in real time.” Here’s what we’ve learned in the process. At ...

The Article Reviews How Personalized Guidance, Monitoring, and Accountability Support Safer Long-Term Weight Management.

By Nqobile Dludla PRETORIA, June 10 (Reuters) - Danish drugmaker Novo Nordisk is heading to court in South Africa on ...

Zealand Pharma's stock is cratering today after disappointing results from a late-stage trial of its GLP-1 dual-receptor ...

The drug works as an appetite suppressant by mimicking a hormone that makes people feel fuller, which can help them lose ...

A phase 2 trial found that apitegromab plus tirzepatide reduced lean body mass loss by 1.9 kg compared with tirzepatide plus ...

A late-stage trial showed retatrutide was effective in weight loss and in alleviating obesity-linked conditions.